Literature DB >> 27139995

Breast cancer: Inhibiting fatty acid oxidation blocks tumour growth.

Sarah Crunkhorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27139995     DOI： 10.1038/nrd.2016.76

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer.

Authors:  Roman Camarda; Alicia Y Zhou; Rebecca A Kohnz; Sanjeev Balakrishnan; Celine Mahieu; Brittany Anderton; Henok Eyob; Shingo Kajimura; Aaron Tward; Gregor Krings; Daniel K Nomura; Andrei Goga
Journal:  Nat Med       Date:  2016-03-07       Impact factor: 53.440
  1 in total
  3 in total

Review 1.  Adipocyte and lipid metabolism in cancer drug resistance.

Authors:  Yihai Cao
Journal:  J Clin Invest       Date:  2019-07-02       Impact factor: 14.808

2.  Metabolite profiling of ascidian Styela plicata using LC-MS with multivariate statistical analysis and their antitumor activity.

Authors:  Satheesh Kumar Palanisamy; Daniela Trisciuoglio; Clemens Zwergel; Donatella Del Bufalo; Antonello Mai
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

3.  CCAT1/FABP5 promotes tumour progression through mediating fatty acid metabolism and stabilizing PI3K/AKT/mTOR signalling in lung adenocarcinoma.

Authors:  Jing Chen; Yaser Alduais; Kai Zhang; Xiaoli Zhu; Baoan Chen
Journal:  J Cell Mol Med       Date:  2021-08-25       Impact factor: 5.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.